NCT05088252View on ClinicalTrials.gov

Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

May 10, 2022

Study Completion Date

May 31, 2022

Conditions
Pituitary Neoplasms
Interventions
DRUG

Desflurane

After induction, anesthesia will be maintained with 0.7-1.0 MAC desflurane and 0.05-0.3 μg/kg/min remifentanil.

DRUG

Propofol

After induction, anesthesia will be maintained with 4-6mg/kg/h propofol and 0.05- 0.3 μg/kg/min remifentanil.

Trial Locations (1)

100070

Ruquan Han, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT05088252 - Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection | Biotech Hunter | Biotech Hunter